Elevated expression of KLK8 predicts poor prognosis in colorectal cancer

Copyright © 2017 Elsevier Masson SAS. All rights reserved..

KLK8, also known as neuropsin, is one of fifteen members of the human kallikrein-related peptidase (KLK) gene family, which consists of enzymes with serine protease enzymatic activity. Aberrant KLK8 expression has been reported in several malignancies. However, the clinicopathological significance and prognostic value of KLK8 expression in colorectal cancer (CRC) are unknown. Therefore, analysis of public datasets, quantitative real-time PCR and western blot analysis were performed to assess KLK8 expression in CRC at both the mRNA and protein level. KLK8 expression was also assessed by immunohistochemistry in a tissue microarray containing 124 CRC specimens. We observed that KLK8 was overexpressed in CRC tissues and was significantly associated with TNM stage, vascular invasion, differentiation and AJCC stage. Univariate and multivariate Cox analyses confirmed that KLK8 is a significant independent prognostic factor for both DFS and OS. Cell function assays also indicated that KLK8 could facilitate CRC cell proliferation, migration and invasion in vitro. In conclusion, elevated KLK8 expression was correlated with the progression of CRC and is a potential independent prognostic indicator for CRC.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:88

Enthalten in:

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 88(2017) vom: 01. Apr., Seite 595-602

Sprache:

Englisch

Beteiligte Personen:

Liu, Xianwu [VerfasserIn]
Quan, Bin [VerfasserIn]
Tian, Zhilong [VerfasserIn]
Xi, Hailin [VerfasserIn]
Jia, Gaolei [VerfasserIn]
Wang, Hui [VerfasserIn]
Zhang, Liang [VerfasserIn]
Liu, Ruming [VerfasserIn]
Ma, Cheng [VerfasserIn]
Han, Fuzhou [VerfasserIn]
Li, Huansong [VerfasserIn]
Yuan, Fukang [VerfasserIn]

Links:

Volltext

Themen:

Colorectal cancer
EC 3.4.21.-
Journal Article
KLK8
KLK8 protein, human
Kallikreins
Prognosis
RNA, Messenger
Tumorigenesis

Anmerkungen:

Date Completed 27.03.2017

Date Revised 16.03.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.biopha.2017.01.112

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM268508275